N@N

The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company

_{//health-fitness.news-articles.net/content/2011/ .. investigation-of-k-v-pharmaceutical-company.html}
^{Published in Health and Fitness on Monday, October 24th 2011 at 11:00 GMT by Market Wire}  

DALLAS--([ BUSINESS WIRE ])--Former United States Securities and Exchange Commission attorney [ Willie Briscoe ], founder of [ The Briscoe Law Firm, PLLC ], and the securities litigation firm of [ Powers Taylor, LLP ] announce that the firms are investigating legal claims against the officers and Board of Directors of K-V Pharmaceutical Company (aKV Pharmaceuticala or aKV-Aa) (NYSE: KV-A) (NYSE: KV-B) related to potential securities violations by KV Pharmaceutical between February 14, 2011 and April 4, 2011 (the aClass Perioda).

If you are an affected investor and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at [ patrick@powerstaylor.com ], or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at [ WBriscoe@TheBriscoeLawFirm.com ]. There is no cost or fee to you.

It has been alleged that during the Class Period, KV Pharmaceutical and certain of its officers and directors made materially false and misleading statements or failed to disclose material information related to the companyas business and operations in violation of the Securities Exchange Act of 1934. Specifically, the complaint alleges that defendants misrepresented that the Food and Drug Administration (FDA) had granted KV Pharmaceutical the exclusive distribution rights over "Makena," a drug used to prevent miscarriages, and that the FDA would enforce those rights by preventing KV Pharmaceuticalas competitors from distributing generic formulations of the drug. The complaint further alleges that defendants failed to disclose that the drugas $1,500 price actually would reduce the availability of Makena to low-income and other at-risk groups. Itas alleged that the defendantsa false statements cause KV Pharmaceuticalas stock to trade at artificially inflated prices during the Class Period.

[ The Briscoe Law Firm, PLLC ] is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

[ Powers Taylor, LLP ] is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.